In the SPD group, the increase in CYP11A1 and CYP17A1 may be attributed to the anti-inflammatory and protective effects of SPD, which could mitigate the negative impact of inflammation on steroidogenic enzymes. Here, CYP11A1 is linked to Platelet storage pool disease.